Fractional CO2 laser and topical latanoprost in acral vitiligo
Not Applicable
- Conditions
- Vitiligo.Vitiligo
- Registration Number
- IRCT20120909010795N4
- Lead Sponsor
- Shiraz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 24
Inclusion Criteria
Age more than 14
Acral vitiligo patche(s) resistant to phototherap
Discontinue all systemic and topical treatments for 1 month
At least 1 lesion in each side with size of 2*2 to 8*8 cm
Exclusion Criteria
Poor compliance
Allergy to latanoprost
Pregnant or breast-feeding women
Age before 14
Uncontrolled systemic disorders that interfere with wound healing process
Autoimmune disorders
History of allergy to any drug
Any psychological disorders
Unilateral lesions
Active infection at laser site
History of keloids
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Skin pigmentation. Timepoint: At the beginning of study and after 5 sessions of laser therapy, at the end of the study. Method of measurement: Qualitative assessment with VASI score and VAS.
- Secondary Outcome Measures
Name Time Method